Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Submitted by
admin
on June 8, 2015 - 10:53am
Source:
Fierce Biotech
News Tags:
Seattle Genetics
immuno-oncology
Unum Therapeutics
Headline:
Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Do Not Allow Advertisers to Use My Personal information
